Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

DC-SIGN/CD209 antibody (FITC)

The Mouse Monoclonal anti-DC-SIGN/CD209 antibody has been validated for FACS and Func. It is suitable to detect DC-SIGN/CD209 in samples from Human.
Catalog No. ABIN1106054

Quick Overview for DC-SIGN/CD209 antibody (FITC) (ABIN1106054)

Target

See all DC-SIGN/CD209 (CD209) Antibodies
DC-SIGN/CD209 (CD209) (CD209)

Reactivity

  • 118
  • 27
  • 21
  • 1
  • 1
Human

Host

  • 79
  • 51
  • 4
  • 1
  • 1
  • 1
Mouse

Clonality

  • 72
  • 65
Monoclonal

Conjugate

  • 64
  • 8
  • 8
  • 7
  • 6
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 3
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
  • 1
This DC-SIGN/CD209 antibody is conjugated to FITC

Application

  • 71
  • 53
  • 45
  • 31
  • 25
  • 19
  • 13
  • 7
  • 6
  • 5
  • 3
  • 3
  • 2
  • 2
  • 1
  • 1
  • 1
Flow Cytometry (FACS), Functional Studies (Func)

Clone

DCN47-5
  • Specificity

    This antibody reacts with the C-type lectin, DC-SIGN (CD209), exclusively expressed on human dendritic cells (DC).

    Cross-Reactivity (Details)

    Species reactivity (tested):Human

    Purification

    Protein G

    Isotype

    IgG1
  • Application Notes

    Optimal working dilution should be determined by the investigator.

    Restrictions

    For Research Use only
  • Concentration

    0.1 mg/mL

    Buffer

    PBS, 0.02 % sodium azide, 1 % bovine serum albumin

    Preservative

    Sodium azide

    Precaution of Use

    This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

    Storage

    4 °C

    Storage Comment

    Store at 2 - 8 °C.
  • Target

    DC-SIGN/CD209 (CD209) (CD209)

    Alternative Name

    CD209 / DC-SIGN

    Background

    DC are specialized antigen presenting cells and bridge the innate and the adaptive immune system. They provide high levels of costimulation necessary for activation of both naive and antigen-experienced T-cells. Immature DC are capable to migrate to inflammatory sites, capture antigen and process it internally to form MHC-peptide complexes. Following antigen uptake, DC undergo maturation and migrate to lymphoid organs where they can present MHC-peptide complexes to resting T-cells and drive T-cell proliferation. During differentiation and maturation of DC, several phenotypic surface markers are expressed: CD1a, CD4, CD11, CD40, CD86, and HLA-DR. Immature DC predominantly express CCR5 which enables DC to migrate to inflammatory sites, whereas mature DC express high levels of CXCR4, a receptor that facilitates migration to lymphoid organs.DC also express DC-specific, ICAM-3 grabbing, nonintegrin (DC-SIGN), a 44 kDa C-type lectin that binds to the HIV-1 envelope glycoprotein gp120, ICAM-3 on T-cells and ICAM-2 on endothelial cells. HIV virions are able to infect cells expressing CD4 and the chemokine co-receptors CCR5 or CXCR4 and can attach to DC-SIGN to extend virion lifespan. Therefore, DC are candidates for HIV-1 infection. DC-SIGN-ICAM-3 binding is integrin-independent but calcium-dependent and antibodies reactive against DC-SIGN can be used to study DC-SIGN-ICAM3 binding.Synonyms: C-type lectin domain family 4 member L, CLEC4L, DC-SIGN1, DCSIGN, DCSIGN1, Dendritic Cell Marker, Dendritic cell-specific ICAM-3-grabbing non-integrin 1

    UniProt

    Q9NNX6
You are here:
Chat with us!